IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
Author:
Affiliation:
1. National Cancer Institute (NCI), Surgery Branch, National Institutes of Health (NIH), Bethesda, MD; and
2. National Heart, Lung and Blood Institute (NHLBI), Laboratory of Molecular Immunology, NIH, Bethesda, MD
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/111/11/5326/1295427/zh801108005326.pdf
Reference65 articles.
1. Programming CD8+ T cells for effective immunotherapy.;Hinrichs;Curr Opin Immunol,2006
2. Principles of adoptive T cell cancer therapy.;June;J Clin Invest,2007
3. Adoptive immunotherapy for cancer: building on success.;Gattinoni;Nat Rev Immunol,2006
4. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.;Rosenberg;N Engl J Med,1985
5. Selective in vitro growth of T lymphocytes from normal human bone marrows.;Morgan;Science,1976
Cited by 355 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Translatability of findings from cynomolgus monkey to human suggests a mechanistic role for IL-21 in promoting immunogenicity to an anti-PD-1/IL-21 mutein fusion protein;Frontiers in Immunology;2024-01-26
2. Engineering Challenges and Opportunities in Autologous Cellular Cancer Immunotherapy;The Journal of Immunology;2024-01-15
3. From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy;Histochemistry and Cell Biology;2024-01-08
4. Biological effects of IL-21 on immune cells and its potential for cancer treatment;International Immunopharmacology;2024-01
5. IL-21-armored B7H3 CAR-iNKT cells exert potent antitumor effects;iScience;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3